Michio Senda

Michio Senda

Auto-generated profile, based on publicly available information

Michio Senda

Department of Molecular Imaging Research, Kobe City Medical Center General Hospital, Kobe, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2014 in Annals of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
HFHiroyoshi Fukukita
Hiroyoshi Fukukita
KSKazufumi Suzuki
Kazufumi Suzuki
KMKeiichi Matsumoto
Keiichi Matsumoto
TTTakashi Terauchi
Takashi Terauchi
HDHiromitsu Daisaki
Hiromitsu Daisaki
MSMichio Senda
Michio Senda
This synopsis outlines the Japanese guideline Version 2.0 for the data acquisition protocol of oncology FDG-PET/CT scans that was created by a joint task force of the Japanese Society of Nuclear Medicine Technology, the Japanese Society of Nuclear Medicine and the Japanese Council of PET Imaging, and was published in Kakuigaku-Gijutsu 2013; 33:377–420 in Japanese. The guideline aims at standardizing the PET image quality among PET centers and different PET camera models by providing criteria for the IEC body phantom image quality as well as for the patient PET image quality based on the noise equivalent count (NEC), NEC density and liver signal-to-noise ratio, so that the appropriate scanning parameters can be determined for each PET camera. This Version 2.0 covers issues that were not focused on in Version 1.0, including the accuracy of the standardized uptake value (SUV), effect of body size together with adjustment of scanning duration, and time-of-flight (TOF) reconstruction technique. Version 2.0 also presents data acquired with new PET camera models that were not tested in Version 1.0. Reference values for physical indicators of phantom image quality have been updated as well.

13 August 2015 in Journal of Nuclear Medicine Technology
Verified
Journal Article
Open access
PDF file
GAGo Akamatsu
Go Akamatsu
YIYasuhiko Ikari
Yasuhiko Ikari
HNHiroyuki Nishida
Hiroyuki Nishida
TNTomoyuki Nishio
Tomoyuki Nishio
AOAkihito Ohnishi
Akihito Ohnishi
MSMichio Senda
Michio Senda
Standardized uptake values (SUVs) have been widely used in the diagnosis of malignant tumors and in clinical trials of tumor therapies as semiquantitative metrics of tumor 18F-FDG uptake. However, SUVs for small lesions are liable to errors due to partial-volume effect and statistical noise. The purpose of this study was to evaluate the reproducibility and accuracy of maximum and peak SUV (SUVmax and SUVpeak, respectively) of small lesions in phantom experiments. Methods: We used a body phantom with 6 spheres in a quarter warm background. The PET data were acquired for 1,800 s in list-mode, from which data were extracted to generate 15 PET images for each of the 60-, 90-, 120-, 150-, and 180-s scanning times. The SUVmax and SUVpeak of the hot spheres in the 1,800-s scan were used as a reference (SUVref,max and SUVref,peak). Coefficients of variation for both SUVmax and SUVpeak in hot spheres (CVmax and CVpeak) were calculated to evaluate the variability of the SUVs. On the other hand, percentage differences between SUVmax and SUVref,max and between SUVpeak and SUVref,peak were calculated for evaluation of the accuracy of SUV. We additionally examined the coefficients of variation of background activity and the percentage background variability as parameters for the physical assessment of image quality. Results: Visibility of a 10-mm-diameter hot sphere was considerably different among scan frames. The CVmax and CVpeak increased as the sphere size became smaller and as the acquisition time became shorter. SUVmax was generally overestimated as the scan time shortened and the sphere size increased. The SUVmax and SUVpeak of a 37-mm-diameter sphere for 60-s scans had average positive biases of 28.3% and 4.4%, compared with the reference. Conclusion: SUVmax was variable and overestimated as the scan time decreased and the sphere size increased. In contrast, SUVpeak was a more robust and accurate metric than SUVmax. The measurements of SUVpeak (or SUVpeak normalized to lean body mass) in addition to SUVmax are desirable for reproducible and accurate quantification in clinical situations.

6 October 2016 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
YIYasuhiko Ikari
Yasuhiko Ikari
GAGo Akamatsu
Go Akamatsu
TNTomoyuki Nishio
Tomoyuki Nishio
KIKenji Ishii
Kenji Ishii
KIKengo Ito
Kengo Ito
MSMichio Senda
Michio Senda
While fluorodeoxyglucose (FDG) and amyloid PET is valuable for patient management, research, and clinical trial of therapeutics on Alzheimer’s disease, the specific details of the PET scanning method including the PET camera model type influence the image quality, which may further affect the interpretation of images and quantitative capabilities. To make multicenter PET data reliable and to establish PET scanning as a universal diagnostic technique and a verified biomarker, we have proposed phantom test procedures and criteria for optimizing image quality across different PET cameras. As the method, four physical parameters (resolution, gray-white contrast, uniformity, and image noise) were selected as essential to image quality for brain FDG and amyloid PET and were measured with a Hoffman 3D brain phantom and a uniform cylindrical phantom on a total of 12 currently used PET models. The phantom radioactivity and acquisition time were determined based on the standard scanning protocol for each PET drug (FDG, 11C-PiB, 18F-florbetapir, and 18F-flutemetamol). Reconstruction parameters were either determined based on the methods adopted in ADNI, J-ADNI, and other research and clinical trials or optimized based on measured phantom image parameters under various reconstruction conditions. As the result, phantom test criteria were proposed as follows: (i) 8 mm FWHM or better resolution and (ii) gray/white %contrast ≥55 % with the Hoffman 3D brain phantom and (iii) SD of 51 small region of interests (ROIs) ≤0.0249 (equivalent to 5 % variation) for uniformity and (iv) image noise (SD/mean) ≤15 % for a large ROI with the uniform cylindrical phantom. These criteria provided image quality conforming to those multicenter clinical studies and were also achievable with most of the PET cameras that are currently used. The proposed phantom test criteria facilitate standardization and qualification of brain FDG and amyloid PET images and deserve further evaluation by future multicenter clinical studies.

1 July 2016 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
AOAkihito Ohnishi
Akihito Ohnishi
MSMichio Senda
Michio Senda
TYTomohiko Yamane
Tomohiko Yamane
TMTomoko Mikami
Tomoko Mikami
HNHiroyuki Nishida
Hiroyuki Nishida
HOHirotaka Onoe
Hirotaka Onoe

1 August 2014 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
AOAkihito Ohnishi
Akihito Ohnishi
MSMichio Senda
Michio Senda
TYTomohiko Yamane
Tomohiko Yamane
MSMasahiro Sasaki
Masahiro Sasaki
TMTomoko Mikami
Tomoko Mikami
HOHirotaka Onoe
Hirotaka Onoe

4 September 2015 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
GAGo Akamatsu
Go Akamatsu
YIYasuhiko Ikari
Yasuhiko Ikari
TNTomoyuki Nishio
Tomoyuki Nishio
HNHiroyuki Nishida
Hiroyuki Nishida
AOAkihito Ohnishi
Akihito Ohnishi
MSMichio Senda
Michio Senda